WonderBiotics vs FloraVantage Control: Which B420 Fits?

WonderBiotics vs Bariatric Advantage FloraVantage Control: Two B420 Formulas Compared

Both products build around Bifidobacterium lactis B420, the probiotic strain behind a widely cited six-month body-fat trial.¹ FloraVantage Control is a single-strain capsule dosed to match that trial's B420 amount. WonderBiotics Probiotics for Weight Management puts B420 into an 8-strain blend with a separate metabolic-support layer, built for a different reader. Which one fits depends on whether you want one strain isolated or broader coverage.

What Is B420, and Why Do Both Brands Use It?

Among B420 probiotic brands, these two sit at opposite ends of the same spectrum. B420 is a commercial name for Bifidobacterium animalis subsp. lactis 420, a strain now licensed by IFF Health (formerly under DuPont Nutrition & Health, acquired by IFF in 2021).² Its main human evidence comes from a 2016 trial funded by DuPont Nutrition & Health, with five of the study's authors employed by DuPont: 225 adults ages 18–65 with a BMI of 28.0–34.9, randomized to placebo, a 12 g/day polydextrose fiber, B420 alone (10¹⁰ CFU/day), or both combined, with sachet contents mixed daily into a provided fruit smoothie for six months. The trial excluded anyone with a history of bariatric surgery or who had used anti-obesity medication in the prior three months.¹

The trial's pre-specified primary endpoint, relative change in DXA-measured body fat mass at six months, showed no significant difference in the intention-to-treat population (209 randomized participants, 199 analyzed using last-observation-carried-forward for missing data; ANCOVA, P=0.46).¹ In the per-protocol population of 134 people who met the study's compliance and protocol criteria (131 of whom were included in the DXA analysis), the combination group (B420 plus fiber) lost significantly more fat mass than placebo (−4.5%, P=0.02); B420 taken alone did not reach significance (−3.0%, P=0.28).¹ A waist-circumference finding (−2.4 cm, P=0.004) came from a post-hoc analysis run after the data were unblinded, pooling both B420-containing arms against both non-B420 arms, not from a head-to-head comparison of B420 alone versus B420 plus fiber.¹ A separate finding from five-day food diaries in that per-protocol group found self-reported daily calorie intake dropped by about 300 kcal/day more with B420 alone than with placebo, and by about 210 kcal/day more with the B420-plus-fiber combination than with placebo. That's a secondary, self-reported result, not the primary fat-mass endpoint.¹ Any brand's marketing that leans on "a six-month clinical study" is drawing from these different evidence tiers, and it matters which tier a specific claim comes from.

Neither Bariatric Advantage's capsule nor WonderBiotics' capsule was the product actually tested: the trial mixed sachet contents into a provided fruit smoothie, not either company's finished formula.¹ Both brands are extrapolating from the raw ingredient's trial data to their own products, which is standard practice in the supplement industry but worth knowing before you weigh the evidence each one cites.

Single-Strain vs. Multi-Strain: How the Two Formulas Differ

FloraVantage Control is built around one ingredient: 10 billion CFU of B. lactis B420 per capsule, guaranteed through expiration, in a simple capsule with microcrystalline cellulose, magnesium stearate, silica, and a vegetarian capsule shell.³ One capsule a day, 30 capsules per bottle. That 10-billion-CFU dose lines up closely with the single-strain arm of the B420 trial, the same arm that did not reach statistical significance on its own for the primary fat-mass endpoint.¹ You know exactly how much B420 you're getting on the label, but the specific dose it matches is the one that needed fiber alongside it, or a post-hoc pooled analysis, to show a measurable difference.

WonderBiotics Probiotics for Weight Management takes a different approach: B420 is one of 8 named strains in a 20-billion-CFU proprietary blend, alongside HN019, L. acidophilus NCFM, L. rhamnosus GG, L. salivarius Ls-33, L. lactis Ll-23, L. paracasei Lpc-37, and L. plantarum Lp-116, plus polydextrose as a prebiotic.⁴ A separate Metabolic Blend adds dihydroberberine and a lemon fruit extract standardized to eriocitrin (marketed as Eriomin).⁴ WonderBiotics does not publish how much of the 20 billion CFU is specifically B420, so you can't do the same dose-matching exercise you can with FloraVantage Control. What you get instead is a formula that layers in HN019, a strain with its own separate human data on whole-gut transit time and functional GI symptoms in adults with infrequent stools,⁵ rather than concentrating the whole product on one strain's single trial.

Does More Strains Mean Better Results? What the Research Shows

A systematic review of 25 randomized trials in 1,931 adults found that trials using multiple probiotic species showed a larger BMI reduction than trials using single-species interventions.⁶ That sounds like a point for multi-strain formulas like WonderBiotics, but it's a comparison across different trials, not a head-to-head test in the same group of people. Those multi-species trials could also have differed in dose, duration, or the population studied, and the review doesn't isolate species count as the cause.⁶ The finding is a signal worth noting, not proof that adding strains is what produced the effect.

As of 2026, no published trial has tested B420 as one ingredient among seven others, and none has tested an 8-strain blend against a single-strain B420 product head-to-head. Neither "more strains" nor "one well-matched strain" has a clean trial win here; both brands are reasoning from indirect evidence, just in different directions. Single-strain dosing lets you verify the exact amount of a specific studied ingredient. WonderBiotics' label includes more named strains, but whether the finished blend produces broader clinical effects beyond what's shown for the individual strains is unknown.

Who FloraVantage Control Is Built For

FloraVantage Control is a Bariatric Advantage product, and it's marketed specifically to people who've had or are preparing for bariatric surgery.³ That's a meaningfully different audience from a general weight-management shopper, and the label's direction to use it as part of a weight-management program guided by a healthcare practitioner reflects that focus.³ If your priority is one specific, well-documented strain at a dose you can verify on the label, and you don't need anything else layered in, FloraVantage Control does that cleanly.

Who WonderBiotics Is Built For

WonderBiotics Probiotics for Weight Management is designed around a different reader: women managing perimenopause or menopause, and people navigating a GLP-1 medication routine (semaglutide, tirzepatide, and similar drugs), who are usually dealing with more than one gut-related concern at once.⁴ That's why the formula doesn't stop at B420. HN019 is included for its own separate data on gut transit time and functional GI symptoms,⁵ and the Metabolic Blend's dihydroberberine and eriocitrin ingredients each have their own preliminary human research outside the probiotic literature altogether (a small five-person absorption study for dihydroberberine, funded by NNB Nutrition with a paid NNB adviser as senior author,⁷ and a blood-sugar trial funded by Eriomin's manufacturer, Ingredients by Nature, showing the Eriomin blend raised GLP-1 levels in people with elevated glucose, in a study measuring blood sugar rather than weight loss⁸). The formula is built on the idea that a single strain can't cover everything our readers are managing at once: hormone-free support, GLP-1 compatibility, and gut coverage beyond one ingredient. WonderBiotics positions this product as a companion to a GLP-1 routine rather than a substitute for the medication or a treatment for its side effects.⁴

Price and What You're Paying For

FloraVantage Control runs $45.85 for a one-time 30-capsule bottle direct from Bariatric Advantage, with subscription pricing down to about $38.97; it's also resold through outlets like Amazon, Walmart, and bariatric-specialty retailers, sometimes for less.³ WonderBiotics Probiotics for Weight Management runs $55.40 one-time, with subscription pricing down to about $41.55 on the longest plan.⁴ The price gap roughly tracks the formula gap: one strain at a verified dose versus eight strains plus a separate metabolic blend. Neither price tells you which approach is right for your situation — that depends on what you're actually trying to solve.

Safety Notes and What Neither Product Can Promise

Probiotics are a dietary supplement category, not a treatment for obesity, and neither product is FDA-evaluated for that use.^{3, 4} If you're on a GLP-1 medication, know that as of 2026, no published human trial has tested any probiotic (B420, HN019, or otherwise) specifically for relieving GLP-1 side effects like nausea or constipation; the one registered trial designed to test this has not yet enrolled participants.⁹ A probiotic alongside a GLP-1 routine can still be a reasonable choice, but any brand's "clinically proven" language about easing those side effects describes the individual strains' history in other populations rather than a test in GLP-1 users themselves. If you're immunocompromised, critically ill, or have a central venous catheter, talk to your doctor before starting any probiotic.¹⁰ And if you've had bariatric surgery, check with your surgical team before adding any new supplement, regardless of which brand you choose.

Which B420 Probiotic Is Best for You

There's no single best B420 supplement for every reader; the best one depends on which problem you're solving. If you want the studied B420 strain at the exact dose used in its own trial, with nothing else in the capsule to account for, FloraVantage Control is the more straightforward single-purpose choice, especially if you're in the post-bariatric-surgery population it's built for. If you're managing perimenopause, menopause, or a GLP-1 routine and want a formula that treats B420 as one piece of a broader gut-and-metabolism strategy rather than the whole plan, WonderBiotics Probiotics for Weight Management is the broader-coverage choice built for that wider brief. Neither product has been tested as its actual finished formula, and neither replaces medical care for obesity. The two products are solving genuinely different problems, and knowing which one is yours determines which formula makes sense for you.

References

1. Stenman LK, Lehtinen MJ, Meland N, et al. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial. EBioMedicine. 2016;13:190-200. PMID 27810310 / PMC5264483
2. IFF Health. HOWARU B420 product page. iff.com/health-sciences/our-products/howaru-b420
3. Bariatric Advantage. FloraVantage Control product page. bariatricadvantage.com/floravantage-control
4. WonderBiotics. Probiotics for Weight Management product page. wonderbiotics.com/products/wonderbiotics-probiotics-for-weight-management
5. Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. PMID 21663486
6. Zhang Q, Wu Y, Fei X. Effect of probiotics on body weight and body-mass index: a systematic review and meta-analysis of randomized, controlled trials. Int J Food Sci Nutr. 2015;67(5):571-580. PMID 27149163
7. Moon JM, Ratliff KM, Hagele AM, Stecker RA, Mumford PW, Kerksick CM. Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial. Nutrients. 2022;14(1):124. PMID 35010998
8. Cesar TB, Ramos FMM, Ribeiro CB. Nutraceutical Eriocitrin (Eriomin) Reduces Hyperglycemia by Increasing Glucagon-Like Peptide 1 and Downregulates Systemic Inflammation: A Crossover-Randomized Clinical Trial. J Med Food. 2022;25(11):1050-1058. PMID 35796695
9. ClinicalTrials.gov. NCT07213323: Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1). clinicaltrials.gov/study/NCT07213323
10. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60(Suppl 2):S129-S134. PMID 25922398